Has David True received payments from drug or device companies?

Yes. Drug and device makers reported $15,764,212 in general payments to David True across 2,282 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David True did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David True come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David True

Rheumatology · Springfield, MONPI 1609854769

Payments from drug & device makers

$15,764,212in general payments, 2019–2025

Across 2,282 payments — averaging $6908.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$7.5M
Modernatx, Inc.$2.4M
AbbVie$2M
Boehringer Ingelheim$593K
Biohaven Pharmaceutical Holding Company Ltd.$554K
Biohaven Pharmaceuticals, Inc.$533K
plus $2.2M from 33 others

$184,988in research payments, 2019–2025

Across 65 payments — averaging $2845.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$111K
Eli Lilly$72K
Regeneron$1K

What the payments were for

Consulting fees$5,77425%
Speaking & faculty fees$1,7107%
Travel & lodging$5,09522%
Food & beverage$10,47745%
Education$3131%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	296	$7,466,442
Modernatx, Inc.	138	$2,388,217
AbbVie(2 entities)	468	$2,039,056
Boehringer Ingelheim	21	$592,888
Biohaven Pharmaceutical Holding Company Ltd.	191	$553,747
Biohaven Pharmaceuticals, Inc.	65	$533,478
Teva Pharmaceuticals USA, Inc.	47	$398,563
H. Lundbeck A S	40	$369,926
Amgen(2 entities)	96	$312,941
Sun Pharmaceutical Industries Inc.	359	$307,877
Regeneron	51	$189,707
Pfizer	141	$157,923
E.r. Squibb & Sons, L.L.C.	14	$150,123
Janssen Research & Development, LLC	32	$101,244
Novartis	27	$89,781
Lexicon Pharmaceuticals, Inc.	15	$33,258
AstraZeneca	17	$30,680
Boehringer Ingelheim International GmbH	52	$19,664
Gilead	3	$9,871
Lundbeck LLC	23	$5,990
Avanir Pharmaceuticals, Inc.	3	$5,422
Currax Pharmaceuticals LLC	1	$2,000
Sanofi	8	$1,838
Lilly USA, LLC	58	$1,044
Johnson & Johnson	41	$726
UCB, Inc.	21	$455
Mallinckrodt Hospital Products Inc.	8	$343
GSK	9	$209
Radius Health, Inc.	10	$186
Bristol Myers Squibb	9	$185
Janssen Scientific Affairs, LLC	3	$155
Genentech USA, Inc.	5	$82
Fresenius Kabi USA, LLC	3	$60
ANI Pharmaceuticals, Inc.	2	$48
Biogen	1	$23
Mylan Institutional Inc.	1	$18
Octapharma USA, Inc.	1	$16
Pacira Therapeutics, Inc.	1	$14
Supernus Pharmaceuticals, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VYEPTI$5,492
KEVZARA$1,688
SAPHNELO$235
ACTHAR$125
Tavneos$125
NURTEC ODT$122
BOTOX$117
EMGALITY$106
REYVOW$106
MOUNJARO$106

How this compares

$15,764,212 in reported general payments places this provider in the 95th percentile of 134 rheumatology providers in Missouri.

See all rheumatology providers in Missouri →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Enbrel MiniEtanercept	11	$94,815
Actemra ActpenTocilizumab	13	$64,900
Hydroxychloroquine Sulfate	35	$1,405
Leflunomide	23	$838
MethotrexateMethotrexate Sodium	33	$696
Prednisone	33	$176
Trazodone Hcl	15	$85

Paid to pharmacies, not to this prescriber.

Other rheumatology in Springfield

Jo Ellen FeugateSpringfield$13K
Joseph MayusSpringfield$4K
Alexis HowardSpringfield$4K
John ErvinKansas City$18.7M
Ghaith NoaisehKansas City$1.6M
Anne WinklerCarthage$1.6M
Alfred KimSaint Louis$1.2M
Tina ShahKansas City$1.2M
Sona KamatSaint Louis$931K
Akgun InceSaint Louis$849K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →